PlainRecalls

Leadiant Biosciences, Inc.

Compiled from official public sources by the publisher.

4 recalls on record · Latest: Feb 22, 2023

Subscribe to new Leadiant Biosciences, Inc. recalls (RSS)

Agency notice ledger

Federal filing book Leadiant Biosciences, Inc. LIGHT-BOOK · SINGLE-AGENCY

#3,007 of 14,151 · 4 notices · 0.004% archive

  • BOOK 4 notices
  • RANK #3,007 of 14,151
  • SHARE 0.004% archive
  • AGENCY FDA Drug (4)
  • CAT drugs
  • CATS 1 category
  • LATEST Feb 22, 2023
  • PHOTO 1 Epic, LLC

Nearest notice-volume peer: 1 Epic, LLC (0 notice gap)

Leadiant Biosciences, Inc. accounts for about 0.004% of the 104,423-notice archive on 4 distinct filings — a light share signal beside absolute volume. FDA · CPSC · USDA FSIS · NHTSA notice stamps for this firm. Read with this firm → · Dominant category → · Similar-volume firm →

Leadiant Biosciences, Inc.'s standing among 14,151 recalling firms

Leadiant Biosciences, Inc. ranks 3,007th of 14,151 tracked firms by distinct recall-event count. Archive size reflects filing volume, not inherent product danger.

Leadiant Biosciences, Inc. vs all firms by recall-notice count

Where this firm's archive sits among every tracked recalling manufacturer

4 3007th of 14151 higher than 10,859 of 14,151 firms

Firms, banded by distinct federal recall-event inventory

Each bar is a band; taller bars hold more firms. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.

Source FDA · CPSC · USDA FSIS · NHTSA federal recall filings · 2026-09-13

Leadiant Biosciences, Inc. in the notice-volume neighbourhood

Distinct federal recall events among this firm and nearest nationwide peers

notices

What this shows Leadiant Biosciences, Inc. holds about 0.004% of archive notices alongside 4 distinct filings.

Source FDA · CPSC · USDA FSIS · NHTSA filings aggregated by PlainRecalls As of September 2026
FDA Drug Moderate Feb 22, 2023

Abelcet (Amphotericin B Lipid Complex) Injection, 5 mg/mL, 100 mg vial, Rx only, Manufactured by Exelead, Inc., Indianapolis, IN 46268; Distributed by Leadiant Biosciences, Inc., Gaithersburg, MD 20878, NDC 57665-101-41
FDA Drug Low Oct 21, 2020

Cystaran (cysteamine ophthalmic solution) 0.44%, For Ophthalmic Use Only, 15 mL bottle, Sterile, Rx Only, Manufactured by Hi-Tech Pharmacal Co Inc., Amityville, NY 11701 for Leadiant Biosciences, Inc., Gaithersburg, MD 20878, NDC 54482-020-01
FDA Drug Low Apr 25, 2018

Cystaran (cysteamine ophthalmic solution) 0.44%, 15 mL bottle, Rx only, Manufactured by Hi-Tech Pharmacal Co. Inc. Amityville, NY 11701 for Leadiant Biosciences, Inc. Gaithersburg, MD 20878, NDC 54482-020-01
FDA Drug Low Mar 7, 2018

Cystaran (cysteamine ophthalmic solution) 0.44%, 15 mL bottle, Rx only, Manufactured by Hi-Tech Pharmacal Co. Inc., Amityville, NY 11701 for Leadiant Biosciences, Inc., Gaithersburg, MD 20878, NDC 54482-020-01

Leadiant Biosciences, Inc. is a small archive contributor

Drug and device firms outside this manufacturer and state, matched by notice volume and category footprint.

Similar recall count

Nearest multi-notice firms by distinct-event totals (4 here).

1 Epic, LLC 4 3rd Day Beverages LLC 4 A.p. Deauville, LLC 4 Aaa Pharmaceutical, Inc. 4 Aap Implantate Ag 4

Similar drugs volume

Nearest multi-notice firms in the same narrow category lane.

Aaa Pharmaceutical, Inc. 4 Advanced Accelerator Applications USA, Inc. 4 Alkermes Inc 4 Allergan 4

Frequently Asked Questions

How many federal recall notices name Leadiant Biosciences, Inc.? ▼
PlainRecalls indexes 4 distinct federal recall events naming Leadiant Biosciences, Inc., aggregated from FDA, CPSC, USDA FSIS, and NHTSA filings (archive as of September 2026). That count is an issuance inventory, not a hazard score.
Where does Leadiant Biosciences, Inc. sit among other recalling firms? ▼
Leadiant Biosciences, Inc. ranks #3,007 of 14,151 by distinct recall-event count among 14,151 firms in this archive (77th percentile of firms with fewer notices). Rank tracks filing frequency, not product danger.
Which agency issues most of Leadiant Biosciences, Inc.'s notices? ▼
FDA Drug accounts for 4 of this firm's 4 indexed notices.
What product category dominates Leadiant Biosciences, Inc.'s filing book? ▼
Filings for Leadiant Biosciences, Inc. span 1 product category, led by drugs. Browse that category archive for peer firms and related notices.
Is a higher notice count more dangerous? ▼
No. Archive size reflects how often federal agencies publish recalls naming the firm — reporting volume, coverage, and product range all move the number. Always verify the individual notice with the issuing agency before acting on a specific product.
Leadiant Biosciences, Inc.: 4 federal recall notices aggregated from FDA, CPSC, USDA FSIS, and NHTSA filings (lead agency FDA Drug). Verify individual notices with FDA directly before acting on a specific recall.

Firm-level totals aggregate distinct federal recall events naming Leadiant Biosciences, Inc.; individual notices remain authoritative on each linked recall page.

Methodology · Corrections · FDA · CPSC · USDA FSIS · NHTSA · Archive as of September 2026